Overall, the discussions highlight the findings that methylphenidate's increased cardiovascular risk is minor, as shown by phrases like 'small — perhaps under 20%' and 'balancing benefits & possible modest risks.' The tone remains cautious but supportive, with users referencing the study's methodology and noting its importance in informing safer clinical decisions.
AgreementModerate agreement
Most discussions acknowledge and support the study's conclusion that the cardiovascular risk from short-term methylphenidate use is small or negligible.
InterestModerate interest
The posts show moderate curiosity, focusing on nuances in the data and risk assessments, indicating genuine engagement with the research findings.
EngagementModerate engagement
Several discussions reference the methods, such as Bayesian analysis, and debate the clinical implications, demonstrating a reasonable level of depth.
ImpactModerate impact
The collective tone suggests the study influences ongoing considerations in ADHD treatment, though no claims of transformative change are made.
Abstract in brief
This study examined whether short-term use of methylphenidate, a medication commonly used for ADHD, increases the risk of cardiovascular events such as heart disease and arrhythmias, using Swedish national registry data.
Results showed that individuals receiving methylphenidate had a slightly higher incidence of cardiovascular events after starting the medication compared to matched controls, but the difference was not statistically significant.
Overall, the study concluded that there is no strong evidence to suggest that short-term methylphenidate use significantly increases the risk of cardiovascular problems.
In our JAMA Network Open @JAMANetworkOpen study, we used Bayesian methods to calculate the probability of cardiovascular adverse events with #methylphenidate treatment for #ADHD: no evidence of risk increased beyond 20%
https://t.co/WDq8XtZjnT https://t.co/Kx7tKMV0Vw
Mar 6, 2024 · 39 likes · 13 shares · 4,076 followersView post →
May 30, 2024 · 17 likes · 1 share · 13,152 followersView post →
SM
Satoru Mitsuboshi
@3stars67664378 · X
Mar 6, 2024 · 5 likes · 1 share · 1,861 followersView post →
MA
Miguel Garcia-Argibay
@argibay_miguel · X
New study suggests small ⚠️ for ♥️ events after starting ADHD med #methylphenidate, but not 20%+ risks as feared. Balancing benefits & possible modest risks still key. More evidence on CV effect size needed - stayed tuned! #ADHD #pharmacoepi #publichealth
https://t.co/1CSfmsMI02
Mar 6, 2024 · 2 likes · 1 share · 28 followersView post →
JO
JAMA Network Open
@JAMANetworkOpen · X
Cohort study examines the risks of cardiovascular disease after 6 months of methylphenidate treatment in individuals with ADHD. https://t.co/HR78h0FZ2X
Mar 6, 2024 · 1 like · 25,411 followersView post →
SC
SFC - Société Française de Cardiologie
@SFCardio · X
Methylphenidate and Short-Term Cardiovascular Risk
ADHD is a complex topic with ongoing research. In this episode, Dr. Jarosaw Jwiak discusses with Professor Stephen Faraone the latest findings in ADHD genetics, treatment options, and the role of biology in managing the…
This video explores the principles of quantum computing, detailing its fundamental concepts and potential applications in various fields. We dive into how quantum bits differ from classical bits and the implications for…
May 30, 2024 · 17 likes · 1 share · 13,152 followersView post →
FD
Frederic Danel
@Frederic_Danel · X
RT @CorteseSamuele: In our JAMA Network Open @JAMANetworkOpen study, we used Bayesian methods to calculate the probability of cardiovascula…
Mar 20, 2024 · 13 shares · 333 followersView post →
I
@investigando
@rocatanho · X
Individuos que reciben metilfenidato tienen un riesgo ligeramente mayor de riesgo CV 6m después de iniciar el tratamiento, aunque es menor del 20%, independientemente de la historia de enfermedad CV #methylphenidate #CVrisk https://t.co/tU3yEXq1Sm
RT @CorteseSamuele: In our JAMA Network Open @JAMANetworkOpen study, we used Bayesian methods to calculate the probability of cardiovascula…
Mar 7, 2024 · 13 shares · 267 followersView post →
AB
Asif M Bachlani
@Asifmbachlani · X
RT @CorteseSamuele: In our JAMA Network Open @JAMANetworkOpen study, we used Bayesian methods to calculate the probability of cardiovascula…
Mar 7, 2024 · 13 shares · 3,614 followersView post →
SS
Silvia Alemany Sierra
@silvialemany · X
RT @CorteseSamuele: In our JAMA Network Open @JAMANetworkOpen study, we used Bayesian methods to calculate the probability of cardiovascula…
Mar 7, 2024 · 13 shares · 303 followersView post →
SM
Satoru Mitsuboshi
@3stars67664378 · X
Mar 6, 2024 · 5 likes · 1 share · 1,861 followersView post →
A
adagajak
@zftjhust · X
RT @CorteseSamuele: In our JAMA Network Open @JAMANetworkOpen study, we used Bayesian methods to calculate the probability of cardiovascula…
Mar 6, 2024 · 13 shares · 201 followersView post →
DA
Dr Cyrus Abbasian
@abbasian · X
RT @CorteseSamuele: In our JAMA Network Open @JAMANetworkOpen study, we used Bayesian methods to calculate the probability of cardiovascula…
Mar 6, 2024 · 13 shares · 1,160 followersView post →
RM
Raman Baweja, MD, MS
@drramanbaweja · X
RT @CorteseSamuele: In our JAMA Network Open @JAMANetworkOpen study, we used Bayesian methods to calculate the probability of cardiovascula…
Mar 6, 2024 · 13 shares · 342 followersView post →
JO
JAMA Network Open
@JAMANetworkOpen · X
Cohort study examines the risks of cardiovascular disease after 6 months of methylphenidate treatment in individuals with ADHD. https://t.co/HR78h0FZ2X
Mar 6, 2024 · 1 like · 25,411 followersView post →
MA
Miguel Garcia-Argibay
@argibay_miguel · X
New study suggests small ⚠️ for ♥️ events after starting ADHD med #methylphenidate, but not 20%+ risks as feared. Balancing benefits & possible modest risks still key. More evidence on CV effect size needed - stayed tuned! #ADHD #pharmacoepi #publichealth
https://t.co/1CSfmsMI02
Mar 6, 2024 · 2 likes · 1 share · 28 followersView post →
NH
Nathalia Le Hen
@NathaliaLeHen · X
RT @CorteseSamuele: In our JAMA Network Open @JAMANetworkOpen study, we used Bayesian methods to calculate the probability of cardiovascula…
Mar 6, 2024 · 13 shares · 2,853 followersView post →
ZL
Zhaolong (Adrian) Li
@AdrianZhaolong · X
RT @CorteseSamuele: In our JAMA Network Open @JAMANetworkOpen study, we used Bayesian methods to calculate the probability of cardiovascula…
RT @CorteseSamuele: In our JAMA Network Open @JAMANetworkOpen study, we used Bayesian methods to calculate the probability of cardiovascula…
Mar 6, 2024 · 13 shares · 537 followersView post →
LL
Lin Li
@LynnLi_S · X
RT @CorteseSamuele: In our JAMA Network Open @JAMANetworkOpen study, we used Bayesian methods to calculate the probability of cardiovascula…
Mar 6, 2024 · 13 shares · 202 followersView post →
SC
Samuele Cortese
@CorteseSamuele · X
In our JAMA Network Open @JAMANetworkOpen study, we used Bayesian methods to calculate the probability of cardiovascular adverse events with #methylphenidate treatment for #ADHD: no evidence of risk increased beyond 20%
https://t.co/WDq8XtZjnT https://t.co/Kx7tKMV0Vw
Mar 6, 2024 · 39 likes · 13 shares · 4,076 followersView post →
T
Kjre15 | TikTok
TikTok
10.1001/jamanetworkopen.2024.1349. Albert R, et al.“Macrolide Antibiotics and the Risk of Cardiac Arrhythmias”. AJRCC. 10.1164/rccm.201402-0385CI #prevencion ...
SC
T
SM
MA
JO
SC
A
FD
I
MM
SC
ND
T
AB
SS
A
DA
RM
NH
ZL
AI
LL